You are here: Home » Articles
Latest Articles & Reviews
- PolyMedic, Inc. (OTCBB: PYMX) $85M (MarketCap) Successfully Completes Phase 1B Clinical Study
- Primary pulmonary hypertension symptoms
- Early Intervention Is Indicated For Treatment of DVT
- Causes, Symptoms, Diagnosis, Prognosis And Latest Treatment For Atrial Fibrillation
- Vitamin K Reduces the Risk for Non-Hodgkin Lymphoma
- Anti-clotting Drug Plavix May Help Treat Lupus
- Warfarin vs. Pradaxa
- FDA Approves New Atrial Fibrillation Medication
- Lovenox: an anticoagulant drug
- An Anticoagulant called Plavix
Sort By
-
PolyMedic, Inc. (OTCBB: PYMX) $85M (MarketCap) Successfully Completes Phase 1B Clinical Study
10/11/2011
PolyMedix, Inc. (OTCBB: PYMX) is an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases. Today, it announced its successful completion of a second Phase 1B clinical sa ... Read more
-
Primary pulmonary hypertension symptoms
10/08/2011
Primary pulmonary hypertension, a rare and life - threatening disease that increases blood pressure in the lungs and damages heart valves, can be treated through a variety of methods, including lifestyle changes, medication, and lung and heart transplant ... Read more
-
Early Intervention Is Indicated For Treatment of DVT
10/06/2011
In the treatment of DVT, (deep vein thrombosis) anticoagulation medical therapy alone isn't enough because it: * Does not dissolve the clot * Waits for the body's own internal mechanism to dissolve the thrombus which can take several months * Leaves r ... Read more
-
Causes, Symptoms, Diagnosis, Prognosis And Latest Treatment For Atrial Fibrillation
10/04/2011
If you have heart beat that is quicker than 60-80 beats per minute at rest or 90-115 beats per minutes during exercise, you might have fast and irregular heart beat or arrhythmia. There are different kinds of arrhythmia but atrial fibrillation (AF) ... Read more
-
Vitamin K Reduces the Risk for Non-Hodgkin Lymphoma
10/01/2011
Researchers at Minnesota's Mayo Clinic have found that people who have higher intakes of vitamin K have a lower risk of developing Non-Hodgkin lymphoma. Those in the top quarter of vitamin K-1, from diet and dietary supplements, had a 45% less risk for ... Read more
-
Anti-clotting Drug Plavix May Help Treat Lupus
09/29/2011
French scientists have discovered that lupus patients have excess blood cells called platelets - small cell fragments that circulate in the blood, clumping together to form clots. These excess and overly-active platelets trigger production of inflammat ... Read more
-
Warfarin vs. Pradaxa
09/27/2011
Pradaxa (chemical name dabigatran) is an anticoagulant medication used to prevent formation of clots that may potentially lead to strokes and embolisms. Pradaxa works by inhibiting factors that lead to potential clot formations. Pradaxa is currently most ... Read more
-
FDA Approves New Atrial Fibrillation Medication
09/24/2011
An FDA panel has unanimously approved a new type of blood-thinning medication, Pradaxa (dabigatran etexilate) to help prevent stroke in people with atrial fibrillation. Atrial fibrillation (AF) is an irregular heartbeat in which the heart's two small upp ... Read more
